Abstract
This chapter discusses salvage therapy in metastatic nonseminomatous germ cell tumor at the University of Texas M.D. Anderson Cancer Center (UTMDACC). The results of salvage chemotherapy at the UTMDACC have resulted in a high cure rate of 58%. The components of therapy were hypothesized that may have contributed to the high cure rate. The salvage treatment strategy was similar in the two groups and consisted of the sequential and frequent delivery of independently effective regimens of BOP, CISCA, POMB, and ACE followed by early surgery for patients with persistent residual disease. Seventy-five percent patients with metastatic chemotherapy–refractory NSGCT of the testis are disease-free with salvage therapy with a median follow-up of 34 months. The higher than anticipated cure rate may be attributed to selection factors or those related to treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
